MaxCyte IncChange company Symbol lookupSelect an option...MXCT MaxCyte IncPAYX Paychex IncPYR Pyrogenesis Canada IncPM Philip Morris International IncGWAV Greenwave Technology Solutions IncSLNO Soleno Therapeutics IncVRPX Virpax Pharmaceuticals IncFDCFF Forum Energy Metals CorpAFMD Affimed NVARVN Arvinas IncGo
MaxCyte, Inc. is a commercial cell engineering company. The Company is focused on providing enabling platform technologies to advance cell-based research and development, as well as next-generation cell therapeutic discovery, development and commercialization. The Company has developed and commercialized its Flow Electroporation platform, which facilitates complex engineering of a variety of cells. Its ExPERT platform is based on its Flow Electroporation technology, which has been designed to address the cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. Its ExPERT platform consists of three instruments, which are known as the ATx, STx, GTx and VLx. Its ATx static electroporation instrument is research focused, performance electroporation platform for small to medium scale transfection. Its STx is used in the field of protein production.
|
|
|
|
| |
Upcoming Events
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| August 9, 2023 | Q2 2023 Earnings Release | -$0.10 | -$0.12 to -$0.08 | -$0.08 |
| May 10, 2023 | Q1 2023 Earnings Release | -$0.11 | -$0.12 to -$0.11 | -$0.04 |
| March 15, 2023 | Q4 2022 Earnings Release | -$0.05 | -$0.08 to -$0.05 | -$0.05 |
| November 9, 2022 | Q3 2022 Earnings Release | -$0.06 | -$0.10 to -$0.06 | -$0.03 |
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
, , , Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.